Industry Urges FDA To Move Faster In Using Models For Regulatory Decisions
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
FDA holds the key to making model-based drug development and drug-disease model libraries successful, speakers at a Jan. 24-25 Drug Industry Association meeting concluded